119 related articles for article (PubMed ID: 8830739)
1. Immunotoxin sensitivity of Chinese hamster ovary cells expressing human transferrin receptors with differing internalization rates.
Recht LD; Raso V; Davis R; Salmonsen R
Cancer Immunol Immunother; 1996 Jul; 42(6):357-61. PubMed ID: 8830739
[TBL] [Abstract][Full Text] [Related]
2. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro.
Recht LD; Griffin TW; Raso V; Salimi AR
Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135
[TBL] [Abstract][Full Text] [Related]
3. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins.
Griffin T; Raso V
Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454
[TBL] [Abstract][Full Text] [Related]
4. The antiproliferative effect of a transferrin-toxin on human retinal pigment epithelial cells and rabbit fibroblasts.
Handa JT; Houston LL; Jaffe GJ
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3419-28. PubMed ID: 8225877
[TBL] [Abstract][Full Text] [Related]
5. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas.
Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL
J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147
[TBL] [Abstract][Full Text] [Related]
6. A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells.
Kawamoto M; Horibe T; Kohno M; Kawakami K
BMC Cancer; 2011 Aug; 11():359. PubMed ID: 21849092
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of antitumor immunotoxins by liposomal monensin.
Griffin T; Rybak ME; Recht L; Singh M; Salimi A; Raso V
J Natl Cancer Inst; 1993 Feb; 85(4):292-8. PubMed ID: 8426373
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin.
Griffin TW; Pagnini PG; Houston LL
J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma.
Griffin TW; Richardson C; Houston LL; LePage D; Bogden A; Raso V
Cancer Res; 1987 Aug; 47(16):4266-70. PubMed ID: 3496960
[TBL] [Abstract][Full Text] [Related]
10. Internalization of the cytotoxic molecules of T101 F(ab')2-(ricin-A-chain) immunotoxin into human T-leukemic cells.
Ravel S; Casellas P
Eur J Biochem; 1990 Sep; 192(2):469-73. PubMed ID: 2209602
[TBL] [Abstract][Full Text] [Related]
11. Transferrin-oligomers as potential carriers in anticancer drug delivery.
Lim CJ; Shen WC
Pharm Res; 2004 Nov; 21(11):1985-92. PubMed ID: 15587919
[TBL] [Abstract][Full Text] [Related]
12. Generation of the soluble transferrin receptor requires cycling through an endosomal compartment.
Rutledge EA; Green FA; Enns CA
J Biol Chem; 1994 Dec; 269(50):31864-8. PubMed ID: 7989360
[TBL] [Abstract][Full Text] [Related]
13. Endocytosis of immunotoxin-791T/36-RTA by tumor cells in relation to its cytotoxic action.
Byers VS; Pawluczyk IZ; Hooi DS; Price MR; Carroll S; Embleton MJ; Garnett MC; Berry N; Robins RA; Baldwin RW
Cancer Res; 1991 Apr; 51(8):1990-5. PubMed ID: 2009518
[TBL] [Abstract][Full Text] [Related]
14. [The Establishment and Identification of Stable CHO Cell Line with Canine Transferrin Receptor Expression].
Zhang W; Yan Y; Bai LG; Zhu YN; Huang L; Sun YN
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 48(1):57-60. PubMed ID: 28612559
[TBL] [Abstract][Full Text] [Related]
15. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.
Zovickian J; Johnson VG; Youle RJ
J Neurosurg; 1987 Jun; 66(6):850-61. PubMed ID: 3033171
[TBL] [Abstract][Full Text] [Related]
16. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
Kornfeld SB; Leonard JE; Mullen MD; Taetle R
Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
[TBL] [Abstract][Full Text] [Related]
17. Monensin is obligatory for the cytotoxic action of a disulfide linked methotrexate-anti-transferrin receptor conjugate.
Raso V; Fehrmann C; Solan VC; Rosowsky A
Biochem Biophys Res Commun; 1988 Jan; 150(1):104-10. PubMed ID: 3276306
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
[TBL] [Abstract][Full Text] [Related]
19. Release of the soluble transferrin receptor is directly regulated by binding of its ligand ferritransferrin.
Dassler K; Zydek M; Wandzik K; Kaup M; Fuchs H
J Biol Chem; 2006 Feb; 281(6):3297-304. PubMed ID: 16354665
[TBL] [Abstract][Full Text] [Related]
20. Impairment of protein trafficking upon overexpression and mutation of optineurin.
Park B; Ying H; Shen X; Park JS; Qiu Y; Shyam R; Yue BY
PLoS One; 2010 Jul; 5(7):e11547. PubMed ID: 20634958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
